PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R102. A total of 37 filers reported holding PLURISTEM THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 1.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $156,000 | -14.3% | 127,000 | 0.0% | 0.00% | -20.0% |
| Q4 2016 | $182,000 | -10.3% | 127,000 | 0.0% | 0.01% | -16.7% |
| Q3 2016 | $203,000 | +48.2% | 127,000 | +23.3% | 0.01% | +50.0% |
| Q2 2016 | $137,000 | -17.5% | 103,000 | 0.0% | 0.00% | -20.0% |
| Q1 2016 | $166,000 | +107.5% | 103,000 | +45.1% | 0.01% | +150.0% |
| Q4 2015 | $80,000 | -49.4% | 71,000 | -17.9% | 0.00% | -60.0% |
| Q3 2015 | $158,000 | -34.7% | 86,500 | -9.7% | 0.01% | -28.6% |
| Q2 2015 | $242,000 | -39.7% | 95,838 | -33.0% | 0.01% | -36.4% |
| Q1 2015 | $401,000 | +76.7% | 143,117 | +57.7% | 0.01% | +57.1% |
| Q4 2014 | $227,000 | +50.3% | 90,750 | +71.2% | 0.01% | +75.0% |
| Q3 2014 | $151,000 | +18.0% | 53,000 | +28.5% | 0.00% | 0.0% |
| Q2 2014 | $128,000 | -16.3% | 41,250 | 0.0% | 0.00% | -20.0% |
| Q1 2014 | $153,000 | +19.5% | 41,250 | +13.2% | 0.01% | +25.0% |
| Q4 2013 | $128,000 | +6.7% | 36,450 | +2.8% | 0.00% | 0.0% |
| Q3 2013 | $120,000 | +11.1% | 35,450 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $108,000 | – | 35,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Verity Asset Management, Inc. | 85,378 | $301,000 | 0.33% |
| Tower Research Capital LLC (TRC) | 54,690 | $193,000 | 0.03% |
| Psagot Value Holdings Ltd. | 54,348 | $191,000 | 0.01% |
| OPPENHEIMER & CO INC | 36,450 | $128,000 | 0.00% |
| MEEDER ASSET MANAGEMENT INC | 2,900 | $10,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 34,571 | $121,000 | 0.00% |
| Commonwealth Equity Services, Inc | 11,100 | $39,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 18,844 | $66,000 | 0.00% |
| CITIGROUP INC | 737 | $3,000 | 0.00% |
| VAN ECK ASSOCIATES CORP | 21,179 | $75,000 | 0.00% |